Search
for
Sort by
Research 421–450 of 1000+
- Effectiveness and Safety of Botulinum Toxin Type A in the Treatment of Androgenetic Alopecia
- Dermatologic Reactions to Targeted Therapy
- Niosomes as Carrier in Dermal Drug Delivery
- A Technique for Reconstruction of Eyebrows and Eyelashes
- Long-Term Superiority of Composite Versus Muscle-Only Free Flaps for Skull Coverage
- Erosive pustular dermatosis of the scalp: causes and treatments
- Minimizing injury to the donor area in follicular unit extraction (FUE) harvesting
- Medical dermatologic conditions in transgender women
- Mesococktails and mesoproducts in aesthetic dermatology
- Distinct Conditions Support a Novel Classification for Bradykinin-Mediated Angio-Oedema
- Hair transplantation for therapy-resistant alopecia areata of the eyebrows: Is it the right choice?
- A systematic review of dermatologic manifestations among adult patients with COVID‐19 diagnosis
- An overview of zinc and its importance in dermatology-Part II: The association of zinc with some dermatologic disorders
- Updates in the understanding and treatments of skin & hair disorders in women of color
- Treatment of scleromyxoedema with hydroxychloroquine
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Efficacy and Safety of Long-Pulsed 755-nm Alexandrite Laser for Keratosis Pilaris: A Split-Body Randomized Clinical Trial
- Latanoprost-induced Skin Depigmentation
- Hirsutism – From Diagnosis to Use of Antiandrogens
- Scalp reduction
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- Investigating the Safety and Efficacy of Platelet-Rich Plasma (PRP) Treatment for Female Androgenetic Alopecia: Review of the Literature
- Proposed mechanisms of low-level light therapy in the treatment of androgenetic alopecia
- Dermatological problems following spinal cord injury in Korean patients
- Treatment of hyperandrogenism in women
- Skin health and integrity
- COVID‐19, androgens, and androgenic alopecia
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Nutritional Clinical Studies in Dermatology
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients